alexa
Reach Us +44-1625-708989
D-Dimer: A Novel Predictor of Survival in Patients with Cardiac Light- Chain Amyloidosis | OMICS International | Abstract
ISSN: 2155-9880

Journal of Clinical & Experimental Cardiology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Research Article

D-Dimer: A Novel Predictor of Survival in Patients with Cardiac Light- Chain Amyloidosis

Xian Cheng#, Fei Xu#, Liuyan Zhang, Fang Zhou, Haifeng Zhang, Xinli Li and Dongjie Xu*

Department of Cardiology, First Affiliated Hospital of Nanjing Medical University, 300 guangzhou road of Nanjing, P.R. China

#Contributed equally to the preparation of the manuscript

*Corresponding Author:
Dongjie Xu
Department of Cardiology
First Affiliated Hospital of Nanjing Medical University, Nanjing, P.R. China
Tel: 18115164197
E-mail: [email protected]

Received date: September 04, 2017; Accepted date: September 13, 2017; Published date: September 18, 2017

Citation: Cheng X, Xu F, Zhang L, Zhou F, Zhang H, et al. (2017) D-Dimer: A Novel Predictor of Survival in Patients with Cardiac Light-Chain Amyloidosis. J Clin Exp Cardiolog 8:541. doi: 10.4172/2155-9880.1000541

Copyright: © 2017 Cheng X, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Background: To identify independent risk factors and predictors of survival in patients with cardiac light chain amyloidosis.

Methods: This study included 26 patients with cardiac AL amyloidosis who were diagnosed by biopsy between October 2009 and January 2016. All the patients were followed up until August 26th, 2016. Baseline clinical data including clinical symptoms, laboratory data, and echocardiographic findings were recorded. Univariate and multivariate Cox proportional hazard regression analyses were performed to identify risk factors for all-cause mortality. The Kaplan-Meier method and log-rank test were used to compare survival times.

Results: In univariate and multivariate analysis, N-terminal pro b-type natriuretic peptide (NT-proBNP) and Ddimer were independent risk factors for all-cause mortality in patients with cardiac AL amyloidosis (P<0.05). The cutoff value of NT-proBNP for 6-month all-cause-mortality was 4509.5 ng/L (sensitivity 73.3%, specificity 77.8%, area under curve (AUC) 67%, 95% confidence interval (CI) 0.442-0.899). The cut-off value of D-dimer for 6-month allcause- mortality was 1.22 mg/L (sensitivity 60%, specificity 90%, AUC 70%, 95% CI: 0.489-0.911). Patients with NTproBNP or D-dimer levels above the cut-off value had a higher all-cause-mortality rate compared to patients below the cut-off value.

Conclusion: D-dimer may be an important biomarker of prognosis in cardiac AL amyloidosis patients.

Keywords

Top